Hyperfine Free Cash Flow 2021-2023 | HYPR
Hyperfine free cash flow from 2021 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Hyperfine Annual Free Cash Flow | |
|---|---|
| 2023 | -42.61 |
| 2022 | -72.92 |
| 2021 | -49.89 |
| 2020 | -23.09 |
| Hyperfine Quarterly Free Cash Flow | |
|---|---|
| 2023-12-31 | -42.61 |
| 2023-09-30 | -32.42 |
| 2023-06-30 | -23.43 |
| 2023-03-31 | -13.55 |
| 2022-12-31 | -72.92 |
| 2022-09-30 | -57.42 |
| 2022-06-30 | -44.45 |
| 2022-03-31 | -27.60 |
| 2021-12-31 | -49.89 |
| 2021-09-30 | -30.78 |
| 2021-06-30 | -19.78 |
| 2021-03-31 | -7.66 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.061B | $0.011B |
| Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn. | |||